Psychedelic drug could help treat depression
The psychedelic drug dimethyltryptamine (DMT) could help treat depression when combined with psychotherapy, The Guardian has reported.
According to preliminary results reported in Nature Medicine, a trial involving 34 patients found that psychotherapy combined with DMT caused a reduction in depressive symptoms, even after the drug had worn off.
Patients with moderate to severe treatment-resistant depression received a single 21.5mg dose of DMT, infused into a vein over 10 minutes. Other participants received a placebo infused the same way. All participants had psychotherapy and follow-up assessments.
According to The Guardian, all patients given DMT saw an improvement in depressive symptoms compared to the placebo group. Patient experience was measured by their scores on a depression questionnaire.
Dr David Erritzoe, a psychiatrist at Imperial College London and lead investigator on the trial, told the publication: “There is an immediate antidepressant effect that is significantly sustained over a three-month period and that’s exciting because this is one session with a drug, embedded in psychological support.”
